ANI Pharmaceuticals Inc (BSFA STU) stock market data APIs
€80.313
0(0%)
as of September 17, 2025
Try our APIs with
free plan!
ANI Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Prev. Close
80.313
Open
80.313
High
80.313
Low
80.313
52 wk Range
49.6-83
Market Cap
1 757 M
Shares Outstanding
21 689 K
Revenue
747 M
EPS
0.76
Beta
0.633
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ANI Pharmaceuticals Inc data using free add-ons & libraries
Get ANI Pharmaceuticals Inc Fundamental Data
ANI Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 747 M
- EBITDA: 104 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-03-09
- EPS/Forecast: 0.67
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ANI Pharmaceuticals Inc News
New
ANI Pharmaceuticals (ANIP) to Post Q2 Earnings: What's in Store?
ANI Pharmaceuticals ANIP is set to report second-quarter 2023 results on Aug 9 before market open, wherein investors are likely to focus on the sales performance of the company’s core business segme...
ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
ANI Pharmaceuticals, Inc. BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release it...
ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $52.79, marking a +1.15% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.4%. At the same time, the Dow ...
ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $51.89, marking a +1.07% move from the previous day. This change outpaced the S&P 500's 0.71% gain on the day. At the same time, the...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
